Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide plus loop diuretics vs high-dose loop diuretics in chronic kidney disease
TCTR20240329006Phase 3Completed
- Sponsor
- Phramongkutklao Hospital
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of acetazolamide in chronic kidney disease (CKD) and hypervolemia (2 arms), sponsored by Phramongkutklao Hospital. Started Sep 2023; status: completed.
02
Drugs
acetazolamide
03
Conditions
chronic kidney disease (CKD)hypervolemia
Beyond the preview
Go deeper on TCTR20240329006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240329006.